ID   SV2B_RAT                Reviewed;         683 AA.
AC   Q63564;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   29-MAY-2024, entry version 141.
DE   RecName: Full=Synaptic vesicle glycoprotein 2B;
DE            Short=Synaptic vesicle protein 2B;
GN   Name=Sv2b; Synonyms=Sv2bb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7681585; DOI=10.1073/pnas.90.6.2150;
RA   Bajjalieh S.M., Peterson K.E., Linial M., Scheller R.H.;
RT   "Brain contains two forms of synaptic vesicle protein 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2150-2154(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=11741278; DOI=10.1006/bbrc.2001.5932;
RA   Heese K., Nagai Y., Sawada T.;
RT   "Identification of a new synaptic vesicle protein 2B mRNA transcript which
RT   is up-regulated in neurons by amyloid beta peptide fragment (1-42).";
RL   Biochem. Biophys. Res. Commun. 289:924-928(2001).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=9648885; DOI=10.1046/j.1471-4159.1998.71010356.x;
RA   Hayashi M., Yamamoto A., Yatsushiro S., Yamada H., Futai M., Yamaguchi A.,
RA   Moriyama Y.;
RT   "Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed
RT   and associated with microvesicles in rat pinealocytes.";
RL   J. Neurochem. 71:356-365(1998).
RN   [4]
RP   GLYCOSYLATION.
RX   PubMed=9801366; DOI=10.1523/jneurosci.18-22-09269.1998;
RA   Janz R., Hofmann K., Suedhof T.C.;
RT   "SVOP, an evolutionarily conserved synaptic vesicle protein, suggests novel
RT   transport functions of synaptic vesicles.";
RL   J. Neurosci. 18:9269-9281(1998).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10625067; DOI=10.1016/s0306-4522(99)00370-x;
RA   Janz R., Suedhof T.C.;
RT   "SV2C is a synaptic vesicle protein with an unusually restricted
RT   localization: anatomy of a synaptic vesicle protein family.";
RL   Neuroscience 94:1279-1290(1999).
RN   [6]
RP   PHOSPHORYLATION BY CK1.
RX   PubMed=10747945; DOI=10.1074/jbc.m000674200;
RA   Pyle R.A., Schivell A.E., Hidaka H., Bajjalieh S.M.;
RT   "Phosphorylation of synaptic vesicle protein 2 modulates binding to
RT   synaptotagmin.";
RL   J. Biol. Chem. 275:17195-17200(2000).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12754292; DOI=10.1177/002215540305100612;
RA   Redecker P., Kreutz M.R., Bockmann J., Gundelfinger E.D., Boeckers T.M.;
RT   "Brain synaptic junctional proteins at the acrosome of rat testicular germ
RT   cells.";
RL   J. Histochem. Cytochem. 51:809-819(2003).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16306227; DOI=10.1242/jcs.02658;
RA   Iezzi M., Theander S., Janz R., Loze C., Wollheim C.B.;
RT   "SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-
RT   evoked granule recruitment.";
RL   J. Cell Sci. 118:5647-5660(2005).
RN   [9]
RP   INTERACTION WITH SYT1.
RX   PubMed=15866046; DOI=10.1016/j.mcn.2004.12.011;
RA   Schivell A.E., Mochida S., Kensel-Hammes P., Custer K.L., Bajjalieh S.M.;
RT   "SV2A and SV2C contain a unique synaptotagmin-binding site.";
RL   Mol. Cell. Neurosci. 29:56-64(2005).
RN   [10]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE A RECEPTOR (MICROBIAL INFECTION),
RP   AND SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=16543415; DOI=10.1126/science.1123654;
RA   Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., Chapman E.R.;
RT   "SV2 is the protein receptor for botulinum neurotoxin A.";
RL   Science 312:592-596(2006).
RN   [11]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPES A AND E RECEPTOR (MICROBIAL
RP   INFECTION), AND SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=18815274; DOI=10.1091/mbc.e08-07-0765;
RA   Dong M., Liu H., Tepp W.H., Johnson E.A., Janz R., Chapman E.R.;
RT   "Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E
RT   into neurons.";
RL   Mol. Biol. Cell 19:5226-5237(2008).
RN   [12]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE F RECEPTOR (MICROBIAL INFECTION),
RP   SUBUNIT (MICROBIAL INFECTION), AND GLYCOSYLATION.
RX   PubMed=19476346; DOI=10.1021/bi9002138;
RA   Fu Z., Chen C., Barbieri J.T., Kim J.J., Baldwin M.R.;
RT   "Glycosylated SV2 and gangliosides as dual receptors for botulinum
RT   neurotoxin serotype F.";
RL   Biochemistry 48:5631-5641(2009).
RN   [13]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE A; E AND F RECEPTOR (MICROBIAL
RP   INFECTION), AND SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=19650874; DOI=10.1111/j.1471-4159.2009.06298.x;
RA   Rummel A., Haefner K., Mahrhold S., Darashchonak N., Holt M., Jahn R.,
RA   Beermann S., Karnath T., Bigalke H., Binz T.;
RT   "Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding
RT   site prior to stimulation-dependent uptake with botulinum neurotoxin F
RT   utilising the three isoforms of SV2 as second receptor.";
RL   J. Neurochem. 110:1942-1954(2009).
RN   [14]
RP   POSSIBLE FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE D RECEPTOR (MICROBIAL
RP   INFECTION), AND SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=21483489; DOI=10.1371/journal.ppat.1002008;
RA   Peng L., Tepp W.H., Johnson E.A., Dong M.;
RT   "Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides
RT   as receptors.";
RL   PLoS Pathog. 7:E1002008-E1002008(2011).
RN   [15]
RP   NOT RECEPTOR FOR C.BOTULINUM NEUROTOXIN TYPE D (MICROBIAL INFECTION), AND
RP   SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=21632541; DOI=10.1074/jbc.m111.254086;
RA   Kroken A.R., Karalewitz A.P., Fu Z., Kim J.J., Barbieri J.T.;
RT   "Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into
RT   neurons.";
RL   J. Biol. Chem. 286:26828-26837(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33 AND THR-36, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [17]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE A2 RECEPTOR (MICROBIAL INFECTION),
RP   SUBUNIT (MICROBIAL INFECTION), AND GLYCOSYLATION.
RX   PubMed=29649119; DOI=10.3390/toxins10040153;
RA   Gustafsson R., Zhang S., Masuyer G., Dong M., Stenmark P.;
RT   "Crystal structure of botulinum neurotoxin A2 in complex with the human
RT   protein receptor SV2C reveals plasticity in receptor binding.";
RL   Toxins 10:0-0(2018).
CC   -!- FUNCTION: Probably plays a role in the control of regulated secretion
CC       in neural and endocrine cells. {ECO:0000250}.
CC   -!- FUNCTION: (Microbial infection) Receptor for C.botulinum neurotoxin
CC       type A (BoNT/A, botA); the toxin binds via extracellular loop 4
CC       (PubMed:16543415). Restores uptake of BoNT/A in mouse and rat cells
CC       that are deleted for SV2 receptor (PubMed:16543415, PubMed:18815274).
CC       Glycosylation of SV2B is not essential for receptor activity, but
CC       enhances the interaction (PubMed:18815274, PubMed:19650874). Also
CC       serves as a receptor for the closely related C.botulinum neurotoxin
CC       type A2; glycosylation is not essential but enhances the interaction
CC       (PubMed:29649119). {ECO:0000269|PubMed:16543415,
CC       ECO:0000269|PubMed:18815274, ECO:0000269|PubMed:19650874,
CC       ECO:0000269|PubMed:29649119}.
CC   -!- FUNCTION: (Microbial infection) Possible receptor for C.botulinum
CC       neurotoxin type D (BoNT/D, botD); BoNT/D does not bind to extracellular
CC       loop 4 as do BoNT/A and BoNT/E (PubMed:21483489). Another group does
CC       not find a convincing interaction with SV2 (PubMed:21632541).
CC       {ECO:0000269|PubMed:21483489, ECO:0000269|PubMed:21632541}.
CC   -!- FUNCTION: (Microbial infection) Receptor for C.botulinum neurotoxin
CC       type E (BoNT/E); the toxin probably binds via extracellular loop 4
CC       (PubMed:18815274). Restores uptake of BoNT/E in mouse cells that are
CC       deleted for SV2 receptor (PubMed:18815274). Glycosylation of SV2B is
CC       not essential for receptor activity, but enhances the interaction
CC       (PubMed:19650874). {ECO:0000269|PubMed:18815274,
CC       ECO:0000269|PubMed:19650874}.
CC   -!- FUNCTION: (Microbial infection) Receptor for C.botulinum neurotoxin
CC       type F (BoNT/F); binding requires glycosylation of this protein
CC       (PubMed:19476346, PubMed:19650874). {ECO:0000269|PubMed:19650874,
CC       ECO:0000305|PubMed:19476346}.
CC   -!- SUBUNIT: Interacts with SYT1 in a calcium-independent manner. Forms a
CC       complex with SYT1, syntaxin-1 and SNAP25 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.botulinum neurotoxin
CC       type A1 and type A2 (BoNT/A, botA) (PubMed:16543415, PubMed:21483489,
CC       PubMed:21632541). Interaction is improved by glycosylation of SV2
CC       (PubMed:29649119). {ECO:0000269|PubMed:16543415,
CC       ECO:0000269|PubMed:19650874, ECO:0000269|PubMed:21483489,
CC       ECO:0000269|PubMed:29649119}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.botulinum neurotoxin
CC       type D (BoNT/D, botD). {ECO:0000269|PubMed:21483489}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.botulinum neurotoxin
CC       type E (BoNT/E) (PubMed:18815274, PubMed:19476346, PubMed:19650874).
CC       Interaction requires glycosylation of SV2 proteins (PubMed:19476346).
CC       {ECO:0000269|PubMed:18815274, ECO:0000269|PubMed:19476346,
CC       ECO:0000269|PubMed:19650874}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.botulinum neurotoxin
CC       type F (BoNT/F) (PubMed:19650874). Interaction requires glycosylation
CC       of SV2 proteins (PubMed:19650874). {ECO:0000269|PubMed:19650874}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle membrane {ECO:0000269|PubMed:16306227,
CC       ECO:0000269|PubMed:7681585}; Multi-pass membrane protein {ECO:0000255}.
CC       Cytoplasmic vesicle, secretory vesicle, acrosome
CC       {ECO:0000269|PubMed:12754292}. Note=Associated with synaptic-like
CC       microvesicles but not with insulin-containing vesicles in insulin-
CC       secreting cells of the pancreas (PubMed:16306227). Localizes to
CC       microvesicles in the pinealocytes. Localizes to the acrosome in
CC       spermatids (PubMed:12754292). {ECO:0000269|PubMed:12754292,
CC       ECO:0000269|PubMed:16306227}.
CC   -!- TISSUE SPECIFICITY: Widely expressed throughout the brain. Specifically
CC       expressed by pinealocytes in the pineal gland. Also detected in testis
CC       (at protein level). Specifically expressed in neural tissues. Expressed
CC       in the spinal cord and in all brain regions with a stronger expression
CC       in hippocampus and cortex. {ECO:0000269|PubMed:10625067,
CC       ECO:0000269|PubMed:12754292, ECO:0000269|PubMed:7681585,
CC       ECO:0000269|PubMed:9648885}.
CC   -!- INDUCTION: By amyloid beta peptide. {ECO:0000269|PubMed:11741278}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:9801366,
CC       ECO:0000305|PubMed:29649119}.
CC   -!- PTM: The N-terminal cytoplasmic domain is phosphorylated by CK1.
CC       {ECO:0000269|PubMed:10747945}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: The use of this protein as a coreceptor for C.botulinum type D
CC       (BoNT/D, botD) is controversial. In double SV2A/SV2B knockout mice
CC       BoNT/D does not degrade its synaptobrevin target; introducing SV2A,
CC       SV2B or SV2C restores target cleavage (PubMed:21483489). However
CC       another group does not find a convincing interaction with SV2
CC       (PubMed:21632541). {ECO:0000269|PubMed:21483489,
CC       ECO:0000269|PubMed:21632541}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L10362; AAA42189.1; -; mRNA.
DR   EMBL; AF372834; AAL47714.1; -; mRNA.
DR   PIR; S34961; S34961.
DR   RefSeq; NP_476555.1; NM_057207.3.
DR   AlphaFoldDB; Q63564; -.
DR   SMR; Q63564; -.
DR   BioGRID; 250769; 2.
DR   IntAct; Q63564; 4.
DR   MINT; Q63564; -.
DR   GlyCosmos; Q63564; 3 sites, No reported glycans.
DR   GlyGen; Q63564; 3 sites, 4 N-linked glycans (2 sites).
DR   iPTMnet; Q63564; -.
DR   PhosphoSitePlus; Q63564; -.
DR   GeneID; 117556; -.
DR   KEGG; rno:117556; -.
DR   UCSC; RGD:619716; rat.
DR   AGR; RGD:619716; -.
DR   CTD; 9899; -.
DR   RGD; 619716; Sv2b.
DR   InParanoid; Q63564; -.
DR   OrthoDB; 2615066at2759; -.
DR   PhylomeDB; Q63564; -.
DR   PRO; PR:Q63564; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0022857; F:transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:InterPro.
DR   GO; GO:0001504; P:neurotransmitter uptake; TAS:RGD.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; ISO:RGD.
DR   Gene3D; 2.160.20.80; E3 ubiquitin-protein ligase SopA; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 2.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   InterPro; IPR022308; SV2.
DR   NCBIfam; TIGR01299; synapt_SV2; 1.
DR   PANTHER; PTHR23511; SYNAPTIC VESICLE GLYCOPROTEIN 2; 1.
DR   PANTHER; PTHR23511:SF2; SYNAPTIC VESICLE GLYCOPROTEIN 2B; 1.
DR   Pfam; PF07690; MFS_1; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 2.
DR   SUPFAM; SSF141571; Pentapeptide repeat-like; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cytoplasmic vesicle; Glycoprotein; Membrane; Neurotransmitter transport;
KW   Phosphoprotein; Receptor; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..683
FT                   /note="Synaptic vesicle glycoprotein 2B"
FT                   /id="PRO_0000239770"
FT   TOPO_DOM        1..110
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        111..131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        132..148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        170..182
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        183..203
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        204..205
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        227..237
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        238..258
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        259..277
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        278..298
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        299..390
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..411
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        412..535
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:16543415"
FT   TRANSMEM        536..556
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        557..565
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        566..586
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        587..592
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        593..613
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        614..626
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        627..649
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        650..653
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        654..672
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        673..683
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        30..47
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        48..65
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         36
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         423
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BG39"
FT   CARBOHYD        441
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        516
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   683 AA;  77502 MW;  BF862EFD4B99EA7B CRC64;
     MDDYRYRDNY EGYAPNDGYY RGNEQNPEED AQSDVTEGHD EEDEIYEGEY QGIPHPDDVK
     SKQTKMAPSR ADGLRGQADL MAERMEDEEQ LAHQYETIID ECGHGRFQWT LFFVLVLALM
     ADGVEVFVVS FALPSAEKDM CLSSSKKGML GLIVYLGMMA GAFILGGLAD KLGRKKVLSM
     SLAINASFAS LSSFVQGYGA FLFCRLISGI GIGGSLPIVF AYFSEFLSRE KRGEHLSWLG
     IFWMTGGIYA SAMAWSIIPH YGWGFSMGTN YHFHSWRVFV IVCALPATVS MVALKFMPES
     PRFLLEMGKH DEAWMILKQV HDTNMRAKGT PEKVFTVSHI KTPKQMDEFI EIQSSTGTWY
     QRWLVRFMTI FKQVWDNALY CVMGPYRMNT LILAVVWFTM ALSYYGLTVW FPDMIRYFQD
     EEYKSKMKVF FGEHVHGATI NFTMENQIHQ HGKLVNDKFI KMYFKHVLFE DTFFDKCYFE
     DVTSTDTYFK NCTIESTTFY NTDLYKHKFI DCRFINSTFL EQKEGCHMDF EEDNDFLIYL
     VSFLGSLSVL PGNIISALLM DRIGRLKMIG GSMLISAVCC FFLFFGNSES AMIGWQCLFC
     GTSIAAWNAL DVITVELYPT NQRATAFGIL NGLCKLGAIL GNTIFASFVG ITKVVPILLA
     AASLVGGGLV ALRLPETREQ VLM
//
